GB0115211D0 - B-cell chronic lymphocytic leukemia - Google Patents

B-cell chronic lymphocytic leukemia

Info

Publication number
GB0115211D0
GB0115211D0 GBGB0115211.5A GB0115211A GB0115211D0 GB 0115211 D0 GB0115211 D0 GB 0115211D0 GB 0115211 A GB0115211 A GB 0115211A GB 0115211 D0 GB0115211 D0 GB 0115211D0
Authority
GB
United Kingdom
Prior art keywords
lymphocytic leukemia
chronic lymphocytic
cell chronic
cell
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0115211.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB0115211.5A priority Critical patent/GB0115211D0/en
Publication of GB0115211D0 publication Critical patent/GB0115211D0/en
Priority to PCT/GB2002/002859 priority patent/WO2003000727A2/en
Priority to PCT/GB2002/002857 priority patent/WO2003000296A2/en
Priority to EP02730533A priority patent/EP1402031A2/en
Priority to AU2002302851A priority patent/AU2002302851A1/en
Priority to US10/481,613 priority patent/US20050085627A1/en
Priority to AU2002310646A priority patent/AU2002310646A1/en
Priority to JP2003507130A priority patent/JP2005505258A/en
Priority to CA002489623A priority patent/CA2489623A1/en
Priority to JP2005259177A priority patent/JP2006081547A/en
Priority to US11/266,699 priority patent/US7364864B2/en
Priority to US12/075,612 priority patent/US20090007280A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
GBGB0115211.5A 2001-06-21 2001-06-21 B-cell chronic lymphocytic leukemia Ceased GB0115211D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0115211.5A GB0115211D0 (en) 2001-06-21 2001-06-21 B-cell chronic lymphocytic leukemia
CA002489623A CA2489623A1 (en) 2001-06-21 2002-06-21 Atopy
AU2002302851A AU2002302851A1 (en) 2001-06-21 2002-06-21 Atopy
PCT/GB2002/002857 WO2003000296A2 (en) 2001-06-21 2002-06-21 Treatment and diagnostic of b cell chronic lymphocytic leukaemia
EP02730533A EP1402031A2 (en) 2001-06-21 2002-06-21 Atopy
PCT/GB2002/002859 WO2003000727A2 (en) 2001-06-21 2002-06-21 Atopy
US10/481,613 US20050085627A1 (en) 2001-06-21 2002-06-21 Atopy
AU2002310646A AU2002310646A1 (en) 2001-06-21 2002-06-21 Treatment and diagnostic of b cell chronic lymphocytic leukaemia
JP2003507130A JP2005505258A (en) 2001-06-21 2002-06-21 ANGE gene in atopy
JP2005259177A JP2006081547A (en) 2001-06-21 2005-09-07 Ange gene in atopy
US11/266,699 US7364864B2 (en) 2001-06-21 2005-11-03 ANGE gene in atopy
US12/075,612 US20090007280A1 (en) 2001-06-21 2008-03-11 Ange gene in atopy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0115211.5A GB0115211D0 (en) 2001-06-21 2001-06-21 B-cell chronic lymphocytic leukemia

Publications (1)

Publication Number Publication Date
GB0115211D0 true GB0115211D0 (en) 2001-08-15

Family

ID=9917097

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0115211.5A Ceased GB0115211D0 (en) 2001-06-21 2001-06-21 B-cell chronic lymphocytic leukemia

Country Status (3)

Country Link
AU (1) AU2002310646A1 (en)
GB (1) GB0115211D0 (en)
WO (1) WO2003000296A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085627A1 (en) * 2001-06-21 2005-04-21 Youming Zhang Atopy

Also Published As

Publication number Publication date
WO2003000296A2 (en) 2003-01-03
AU2002310646A1 (en) 2003-01-08
WO2003000296A3 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
GB0121820D0 (en) Inkjet deposition apparatus
IL157969A0 (en) Melanocortin receptor ligands
HK1070071A1 (en) New pyrimidine compounds
EP1421057A4 (en) Chemotherapeutic agents
GB0121817D0 (en) Inkjet deposition apparatus
GB0106918D0 (en) VoIP SYSTEMS
AU2003272511A8 (en) Cd44-binding ligands
DE60303390D1 (en) Sulfonierte aliphatisch-aromatische copolyetherester
GB0121814D0 (en) Inkjet deposition apparatus
GB2397178B (en) N port feed device
GB0207362D0 (en) Chemotherapy
GB0208516D0 (en) Chemotherapy
AU149383S (en) Router
GB0027552D0 (en) Anti-tumor compounds
EP1427426A4 (en) Gpi-anchored cytokines
AU2003283562A8 (en) Ligands
GB0104838D0 (en) Pathfinder
EP1460574A4 (en) Multiplier
GB0110837D0 (en) A router
GB0115211D0 (en) B-cell chronic lymphocytic leukemia
EP1558617A4 (en) Amidine compounds
GB0221802D0 (en) Leukemia
GB0116643D0 (en) Antiviral compounds
GB0200970D0 (en) Identifying chemotherapeutic compounds
GB0123947D0 (en) Chemotherapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)